New strategies in the treatment and prevention of allergic diseases

2004 ◽  
Vol 13 (2) ◽  
pp. 107-124 ◽  
Author(s):  
Hans Michael Haitchi ◽  
Stephen T Holgate
Keyword(s):  
Allergic Diseases ◽  
Treatment And Prevention ◽  
New Strategies

THE ROLE OF PHAGE THERAPY IN THE FORMATION OF THE INTESTINAL MICROECOSYSTEM

2020 ◽  
pp. 183-191
Author(s):  
Gladkov S.F. ◽  
Perevoshchikova N.K. ◽  
Chernykh N.S. ◽  
Pichugina Yu.S. ◽  
Surkova M.A.
Keyword(s):  
Intestinal Microbiota ◽  
Allergic Diseases ◽  
Evidence Base ◽  
Immunological Tolerance ◽  
Convincing Evidence ◽  
Selective Decontamination ◽  
Genetic Characteristics ◽  
Treatment And Prevention ◽  
Intestinal Infections ◽  
The Individual

The current adverse situation associated with the presence of a pandemic of allergic diseases is due to the lack of a scientifically based concept of treatment and prevention. The increased interest of researchers from different countries in the formation of immunological tolerance by modeling the intestinal microbiota is of high importance. Methods of influence on the microbial communities of the child's intestine should be as delicate as possible, taking into account the individual genetic characteristics of the microecosystem and the possibility of anaphylaxis. Until now, probiotic drugs have been widely used to correct dysbiosis, but data is gradually accumulating that there is no convincing evidence base for their use for the treatment and prevention of atopy. The use of bacteriophages is very relevant and one of the promising, actively studied areas of correction of intestinal biocenosis today, which are an alternative to antibiotic and probiotic medications. Selective decontamination of representatives of opportunistic flora, as the main factor in the implementation of the atopic phenotype, makes it possible to preserve and accelerate the formation of a unique and individual composition of the intestinal microbiota of the child, which can form an immunoregulatory balance. More than a century of experience in the use of bacteriophages indicates the safety of their use. Today, bacteriophages are actively used in various fields of practical medicine − obstetrics-gynecology, perinatology, urology, pediatric otorhinolaryngology, in the treatment of purulent-septic and intestinal infections. In some cases, bacteriophages are very effective against antibiotic-resistant pathogens. The active personalized use of bacteriophages in real clinical practice will make it possible to solve a number of serious, long-standing health problems in the Russian Federation and to win a world priority in this direction.

Climate change and its impact on the development of allergic diseases

2021 ◽  
Vol 17 (4) ◽  
pp. 7-18
Author(s):  
Evgeniya V. Nazarova
Keyword(s):  
Air Pollution ◽  
Respiratory System ◽  
Forest Fires ◽  
Negative Impact ◽  
Allergic Diseases ◽  
Developed Countries ◽  
Dust Storms ◽  
International Studies ◽  
Treatment And Prevention ◽  
Earth Temperature

Since the middle of the twentieth century, there has been a widespread increase in the prevalence of allergic diseases, especially in developed countries. Much attention is paid to the changing climate and its influence on the development of allergies, mainly of the respiratory system. In many countries, studies are intensifying to study the relationship of various weather phenomena, air pollution, Earth temperature with the course of certain allergic diseases of the respiratory tract. Global strategies for the treatment and prevention of allergic diseases are being developed. This review provides data from international studies demonstrating the negative impact on human health and the development of allergic diseases of the respiratory system, in particular asthma: a global rise in Earth temperature, air pollution, dust storms, forest fires, dampness in rooms and atmospheric mold, thunderstorms and floods.

On the importance of psychological factors in allergic diseases in children

1999 ◽  
Vol 80 (3) ◽  
pp. 219-221
Author(s):  
I. S. Aron ◽  
A. M. Potemkin
Keyword(s):  
Allergic Disease ◽  
Psychological Factors ◽  
Allergic Diseases ◽  
First Year ◽  
Childhood Diseases ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
First Year Of Life

Allergic diseases account for 20-25% in the overall structure of all morbidity in Russia [5]. The problem of prevention and treatment of allergic diseases in children is especially urgent, because allergic diseases occupy a leading place in the structure of childhood diseases. According to A.M. Potemkina, treatment and prevention of allergic diseases in children are most effective in the first three years of life. In children of the first year of life, monoallergy prevails, that is, one allergic disease (85%).

Correlation between severity of migraine attacks and IgE level in peripheral blood

2016 ◽  
Vol 40 (3) ◽  
Author(s):  
Maryam Hassanpour Moghadam ◽  
Hamidreza Ardalani ◽  
Alireza Alehashemi ◽  
Mahboobeh Adami Dehkordi ◽  
Mojtaba Meshkat
Keyword(s):  
Inflammatory Mediators ◽  
Peripheral Blood ◽  
Migraine Headache ◽  
Clinical Symptoms ◽  
Allergic Sensitization ◽  
Allergic Diseases ◽  
University Hospital ◽  
Migraine Headaches ◽  
Treatment And Prevention ◽  
Significant Difference

Abstract: The correlation between allergic diseases and migraine is partially due to a better understanding of inflammatory mediators with vasoactive function that play an important role in these diseases. This study aimed to evaluate the correlation between allergic sensitization and severity of migraine.: This study was carried out on 212 patients who suffered from migraine headache in a university hospital in Mashhad, Iran. All of these patients were evaluated for allergic rhinitis (AR) by measuring the IgE level in peripheral blood and assessing the clinical symptoms of AR. Prevalence of AR in migraine patients and degree of allergic sensitization was assessed in this study.: The prevalence of AR in migraine patients was 78.30%. Total IgE levels in the peripheral blood in migraine patients with AR were found to be significantly (p<0.0001) higher than those without migraines. There was a significant difference between severity of AR (higher level of IgE) and severity of migraine attacks (p<0.0001), but there was not any significant difference between severity of AR and other factors.: We propose that inflammatory mediators play a key role in triggering migraine attacks. Thus, effective treatment of AR in migraine patients plays an important role in treatment and prevention of migraine headaches.

scholarly journals Allergy and obesity in children: is there any link?

2021 ◽  
pp. 17-26
Author(s):  
Natalia Begievna Migacheva ◽  
Dariia Alekseevna Rakcheeva ◽  
Olga Viktorovna Skvortsova ◽  
Evgeniia Gennadevna Mikhailova
Keyword(s):  
Mutual Influence ◽  
Pediatric Population ◽  
Allergic Diseases ◽  
Current Data ◽  
Steady Increase ◽  
Laboratory Studies ◽  
Prevention Strategies ◽  
Causal Factors ◽  
Treatment And Prevention ◽  
Obesity In Children

The steady increase in the prevalence of non-communicable diseases in the population, including obesity and allergic diseases, dictates the need to study both common causal factors and mechanisms of their development, and to search for new effective treatment and prevention strategies. However the resultsof epidemiologic, clinical and laboratory studies are still inconclusive, especially in pediatric population. In this review we present and discuss current data that may help to understand the possible relationship and mechanisms of mutual influence of allergy and obesity in children.

scholarly journals Actual aspects of use of ergoferon in outpatient polyclinic practice

2018 ◽  
pp. 90-95
Author(s):  
O. V. Fesenko
Keyword(s):  
Active Drug ◽  
Respiratory Infections ◽  
Age Groups ◽  
Allergic Diseases ◽  
Risk Groups ◽  
Acute Respiratory Infections ◽  
Antiviral Immune Response ◽  
Treatment And Prevention ◽  
Distinctive Property ◽  
Preclinical And Clinical Studies

Acute respiratory infections (ARI) and influenza are referred to the most common diseases among children and adults. Despite a wide choice of medications for this pathology, we still need ones that combine a multipurpose antiviral activity, have proven effectiveness and safety and enable application in patients from risk groups, including allergic diseases. The pharmacological activity of a release-active drug Ergoferon is determined by the complex action of its components on antiviral immune response and virus-induced inflammation in the respiratory tract. Each component at the same time has its own target modulating action, which is a distinctive property of release-active antibodies forms. The article presents an overview of Russian and foreign publications, summarizing the results of preclinical and clinical studies effectiveness and safety of the Ergoferon use for treatment and prevention of acute respiratory infections and influenza in patients of different age groups.

β-Glucans in the treatment and prevention of allergic diseases

2014 ◽  
Vol 42 (2) ◽  
pp. 149-156 ◽  
Author(s):  
Milos Jesenak ◽  
Peter Banovcin ◽  
Zuzana Rennerova ◽  
Juraj Majtan
Keyword(s):  
Allergic Diseases ◽  
Treatment And Prevention

scholarly journals The art of shampoos in canine and feline dermatology: Treatment and prevention strategies

2017 ◽  
Vol 56 (2) ◽  
pp. 162
Author(s):  
D. N. CARLOTTI ◽  
H. GATTO
Keyword(s):  
Skin Diseases ◽  
Topical Therapy ◽  
Allergic Diseases ◽  
Parasitic Diseases ◽  
Prevention Strategies ◽  
Bacterial Diseases ◽  
Current Technology ◽  
Treatment And Prevention ◽  
Allergic Skin ◽  
Microbiological Agents

This paper reviews the current technology pertaining to veterinary shampoos used for dogs and cats. The criteria used to evaluate their efficacy are presented. The indications for the use of shampoos in keratoseborrhoeic disorders, parasitic diseases, bacterial diseases, fungal diseases and allergic diseases are reviewed. In keratoseborrhoeic disorders both keratomodulating and antiseborrhoeic agents are used. Antiparasitic shampoos are not frequendy used in veterinary dermatology and their indications and limitations are discussed. Antibacterial, antifungal and antiseptic agents are included in shampoos designed to treat dermatoses resulting from microbiological agents. Their indications and efficacy are presented. Shampoos are used nowadays in conjunction with other forms of therapy to treat allergic skin diseases. The benefits of such adjunctive topical therapy are discussed. Lastly, the properties of moisturizers are presented and the value of their use in combination with therapeutic shampoos is emphasized.

scholarly journals POLYCOMPONENT VACCINE IMMUNOVAC-VP-4 AND IMMUNOTHERAPEUTIC CONCEPT OF ITS USE FOR THE PREVENTION AND TREATMENT OF DISEASES CAUSED BY OPPORTUNISTIC MICROORGANISMS

2019 ◽  
Vol 1 (1) ◽  
pp. 43-49 ◽  
Author(s):  
N. B. Egorova ◽  
E. A. Kurbatova ◽  
N. K. Akhmatova ◽  
I. M. Gruber
Keyword(s):  
Dendritic Cells ◽  
Clinical Effect ◽  
Viral Infections ◽  
Respiratory Infections ◽  
Interspecific Cross ◽  
Allergic Diseases ◽  
Immunological Parameters ◽  
Treatment And Prevention ◽  
Acute Respiratory Diseases

Aim. Analysis of experimental data and results of long-term clinical studies of immunotherapeutic and prophylactic effectiveness of a polycomponent vaccine, Immunovac-VP-4. Materials and methods. Immunogenic strains of Staphylococcus aureus, Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli, which antigens possessed broad intra — and interspecific cross-protective activity were selected to obtain the vaccine. Immunological parameters were determined using flow cytometry with the use of diagnostic monoclonal antibodies to cytokines, Toll-like receptors, surface molecules of dendritic cells and lymphocytes. The clinical effect of Immunovac-VP-4 was evaluated in chronic inflammatory and allergic diseases, as well as in the prevention of acute respiratory diseases (ARI) in children’s organized groups. Results. Immunovac-VP-4, protected the mice from infection caused by etiologically significant strains of bacteria and viruses, increased TLR-2, 4, 9-expressing cells; maturing the dendritic cells; the synthesis of cytokines IL1β, IL-6, IL-10, IL-12, IFNγ,; proliferation and increased cytotoxicity of NK cells. Significant clinical effect (69.2 — 100)% of Immunovac-VP-4 on the background of the basic therapy was obtained in patients with chronic inflammatory and allergic diseases. The therapeutic effect was accompanied by a positive dynamics of immunological parameters, in particular, an increase in IFNγ and a decrease in IL-4. Immunotherapy and immunoprophylaxis using Immunovac-VP-4 led to a decrease in the number of episodes of acute respiratory infections and their bacterial complications, including children in organized groups. Conclusion. Immunological feasibility of using Immunovac-VP-4 in complex treatment and prevention of bacterial and viral infections, caused by opportunistic microorganisms, as well as in allergic diseases was proved. 

Sign in / Sign up

Export Citation Format

Share Document